vs
Apellis Pharmaceuticals, Inc.（APLS）与STRATASYS LTD.（SSYS）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是STRATASYS LTD.的1.5倍（$199.9M vs $137.0M），Apellis Pharmaceuticals, Inc.净利率更高（-29.5% vs -40.6%，领先11.1%），STRATASYS LTD.同比增速更快（-2.2% vs -5.9%），STRATASYS LTD.自由现金流更多（$2.5M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -7.4%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Stratasys是一家美以合资的增材制造企业，总部注册于以色列，主营聚合物3D打印设备、配套软件与打印材料，同时按需提供3D打印零部件服务。其3D打印方案被工程领域广泛采用，可加工ABS、聚碳酸酯、尼龙12等多种聚合物材料，适配复杂几何构件的建模生产。
APLS vs SSYS — 直观对比
营收规模更大
APLS
是对方的1.5倍
$137.0M
营收增速更快
SSYS
高出3.8%
-5.9%
净利率更高
APLS
高出11.1%
-40.6%
自由现金流更多
SSYS
多$16.7M
$-14.3M
两年增速更快
APLS
近两年复合增速
-7.4%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $137.0M |
| 净利润 | $-59.0M | $-55.6M |
| 毛利率 | — | 41.0% |
| 营业利润率 | -25.6% | -16.6% |
| 净利率 | -29.5% | -40.6% |
| 营收同比 | -5.9% | -2.2% |
| 净利润同比 | -62.2% | -109.0% |
| 每股收益（稀释后） | $-0.40 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSSSYS
| Q4 25 | $199.9M | — | ||
| Q3 25 | $458.6M | $137.0M | ||
| Q2 25 | $178.5M | $138.1M | ||
| Q1 25 | $166.8M | $136.0M | ||
| Q4 24 | $212.5M | — | ||
| Q3 24 | $196.8M | $140.0M | ||
| Q2 24 | $199.7M | $138.0M | ||
| Q1 24 | $172.3M | $144.1M |
净利润APLSSSYS
| Q4 25 | $-59.0M | — | ||
| Q3 25 | $215.7M | $-55.6M | ||
| Q2 25 | $-42.2M | $-16.7M | ||
| Q1 25 | $-92.2M | $-13.1M | ||
| Q4 24 | $-36.4M | — | ||
| Q3 24 | $-57.4M | $-26.6M | ||
| Q2 24 | $-37.7M | $-25.7M | ||
| Q1 24 | $-66.4M | $-26.0M |
毛利率APLSSSYS
| Q4 25 | — | — | ||
| Q3 25 | — | 41.0% | ||
| Q2 25 | — | 43.1% | ||
| Q1 25 | — | 44.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 44.8% | ||
| Q2 24 | — | 43.8% | ||
| Q1 24 | — | 44.4% |
营业利润率APLSSSYS
| Q4 25 | -25.6% | — | ||
| Q3 25 | 48.7% | -16.6% | ||
| Q2 25 | -18.6% | -12.0% | ||
| Q1 25 | -50.0% | -9.1% | ||
| Q4 24 | -12.3% | — | ||
| Q3 24 | -24.0% | -18.2% | ||
| Q2 24 | -14.7% | -18.9% | ||
| Q1 24 | -36.0% | -17.0% |
净利率APLSSSYS
| Q4 25 | -29.5% | — | ||
| Q3 25 | 47.0% | -40.6% | ||
| Q2 25 | -23.6% | -12.1% | ||
| Q1 25 | -55.3% | -9.6% | ||
| Q4 24 | -17.1% | — | ||
| Q3 24 | -29.2% | -19.0% | ||
| Q2 24 | -18.9% | -18.6% | ||
| Q1 24 | -38.5% | -18.0% |
每股收益（稀释后）APLSSSYS
| Q4 25 | $-0.40 | — | ||
| Q3 25 | $1.67 | — | ||
| Q2 25 | $-0.33 | — | ||
| Q1 25 | $-0.74 | — | ||
| Q4 24 | $-0.30 | — | ||
| Q3 24 | $-0.46 | — | ||
| Q2 24 | $-0.30 | — | ||
| Q1 24 | $-0.54 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $71.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $852.5M |
| 总资产 | $1.1B | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSSSYS
| Q4 25 | $466.2M | — | ||
| Q3 25 | $479.2M | $71.5M | ||
| Q2 25 | $370.0M | $71.1M | ||
| Q1 25 | $358.4M | $70.1M | ||
| Q4 24 | $411.3M | — | ||
| Q3 24 | $396.9M | $64.0M | ||
| Q2 24 | $360.1M | $70.9M | ||
| Q1 24 | $325.9M | $91.1M |
总债务APLSSSYS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSSSYS
| Q4 25 | $370.1M | — | ||
| Q3 25 | $401.2M | $852.5M | ||
| Q2 25 | $156.3M | $902.4M | ||
| Q1 25 | $164.2M | $784.8M | ||
| Q4 24 | $228.5M | — | ||
| Q3 24 | $237.1M | $831.8M | ||
| Q2 24 | $264.3M | $850.5M | ||
| Q1 24 | $266.7M | $866.1M |
总资产APLSSSYS
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $821.4M | $1.1B | ||
| Q1 25 | $807.3M | $1.0B | ||
| Q4 24 | $885.1M | — | ||
| Q3 24 | $901.9M | $1.1B | ||
| Q2 24 | $904.5M | $1.1B | ||
| Q1 24 | $831.9M | $1.1B |
负债/权益比APLSSSYS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $6.9M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $2.5M |
| 自由现金流率自由现金流/营收 | -7.1% | 1.8% |
| 资本支出强度资本支出/营收 | 0.1% | 3.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $-11.5M |
8季度趋势，按日历期对齐
经营现金流APLSSSYS
| Q4 25 | $-14.2M | — | ||
| Q3 25 | $108.5M | $6.9M | ||
| Q2 25 | $4.4M | $-1.1M | ||
| Q1 25 | $-53.4M | $4.5M | ||
| Q4 24 | $19.4M | — | ||
| Q3 24 | $34.1M | $-4.5M | ||
| Q2 24 | $-8.3M | $-2.4M | ||
| Q1 24 | $-133.0M | $7.3M |
自由现金流APLSSSYS
| Q4 25 | $-14.3M | — | ||
| Q3 25 | $108.3M | $2.5M | ||
| Q2 25 | $4.4M | $-8.4M | ||
| Q1 25 | $-53.4M | $789.0K | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | — | $-6.3M | ||
| Q2 24 | $-8.4M | $-4.9M | ||
| Q1 24 | $-133.3M | $5.0M |
自由现金流率APLSSSYS
| Q4 25 | -7.1% | — | ||
| Q3 25 | 23.6% | 1.8% | ||
| Q2 25 | 2.5% | -6.1% | ||
| Q1 25 | -32.0% | 0.6% | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | — | -4.5% | ||
| Q2 24 | -4.2% | -3.6% | ||
| Q1 24 | -77.3% | 3.5% |
资本支出强度APLSSSYS
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | 3.2% | ||
| Q2 25 | 0.0% | 5.3% | ||
| Q1 25 | 0.0% | 2.8% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | 1.3% | ||
| Q2 24 | 0.0% | 1.8% | ||
| Q1 24 | 0.2% | 1.6% |
现金转化率APLSSSYS
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
SSYS
暂无分部数据
